The use of the anti-malaria drug Fansidar® (pyrimethamine and sulphadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency

British Journal of Haematology

Volumn 102, Issue 2, 1998, Pages 578-581

  Van Der Werff Ten Bosch, Jutte E ^a,b   Demanet, Christian ^a   Balduck, Nadine ^b   Bakkus, Marleen H C ^a   De Raeve, Hendrik ^b   Desprechins, Brigitte ^b   Otten, Jaques ^b   Thielemans, Kris ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Autoimmune lymphoproliferative syndrome; Fansidar; Fas deficiency; Pyrimethamine; Sulphadoxine

Indexed keywords

FANSIDAR; FAS ANTIGEN; PYRIMETHAMINE; SULFADOXINE;

APOPTOSIS; ARTICLE; DRUG USE; GENE MUTATION; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MALARIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANTIGENS, CD95; ANTIMALARIALS; AUTOIMMUNE DISEASES; DRUG COMBINATIONS; HUMANS; INFANT; LYMPHOPROLIFERATIVE DISORDERS; PYRIMETHAMINE; SULFADOXINE; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031817818     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00791.x     Document Type: Article

References (9)

1. Benkerrou, M., Le Deist, F., de Villartay, J.P., Caillat-Zucman, S., Jabado, N., Cavazzana-Calvo, M. & Fischer, A. (1997) Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation, European Journal of Immunology, 27, 2043-2047.
2. Drappa. J., Vaishnaw, A.K., Sullivan, K.E., Chu, J.L. & Elkon, K.B. (1996) Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associaited with autoimmunity. New England Journal of Medicine, 335, 1643-1649.
3. Fisher, G.H., Rosenberg, E.J., Straus, S.E., Dale. J.K., Middelton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J. & Puck, J.M. (1995) Dominant interfering Fas gene mutations impair apoplosis in a human lymphoproliferative syndrome. Cell, 81, 935-946.
4. Friesen, C., Herr, L. Krammer, P.H. & Debatin, K.M. (1996) Involvement of the CD95 cAPO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukaemia cells. Nature Medicine, 2, 574-577.
5. Fuss, I.J., Strober, W., Dale, J.K., Fritz, S., Pearlstein, G.R., Puck, J.M., Lenardo, M.J. & Straus, S.E. (1997) Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. Journal of Immunology, 158, 1912-1918.
6. Le Deist, F., Emile, J.E. Rieux-Laucat, E. Benkerrou, M., Roberts, I., Brousse, N. & Fischer, A. (1996) Clinical, immunological and pathological consequences of Fas-deficient conditions. Lancet, 348, 719-723.
7. Rieux-Laucat, Le Deist, F., Hivroz, C., Roberts, I.A.G., Debatin, K.M., Fischer, A. & de Villartay, J.P. (1995) Mutations in Fas associated with lymphoproliferative syndrome and autoimmunity. Science, 268, 1347-1349.
8. Sneller, M.C., Wang. J., Dale, J.K., Stroher, W. Middelton, L.A., Choi, Y., Fleisher, T.A., Lim, M.S., Jaffe, E.S., Puck, J.M., Lenardo, M.J. & Strauss, S.E. (1997) Clinical, immunological and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood, 89, 1341-1348.
9. Sturchler, D., Schar, M. & Gyr, N. (1987) Leucopenia and abnormal liver function in travellers on malaria chemoprophylaxis. Journal of Tropical Medicine and Hygiene, 90, 239-243.